The possible mechanism of rhapontigenin influencing antifungal activity on Candida albicans

References

• Ouwehand A, Isolauri E, Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr 2002; 41(Suppl. 1): 132–137.
   PubMed Web of Science ®Google Scholar
• Yang C, Gong W, Lu J, Zhu X, Qi Q. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to amphotericin B. J Oral Pathol Med 2010; 39: 182–187.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419–4431.
   PubMed Web of Science ®Google Scholar
• Baginski M, Czub J. Amphotericin B and its new derivatives – mode of action. Curr Drug Metab 2009; 10: 459–469.
   PubMed Web of Science ®Google Scholar
• Morris MI, Villmann M. Echinocandins in the management of invasive fungal infections, part 1. Am J Health Syst Pharm 2006; 63: 1693–1703.
   PubMed Web of Science ®Google Scholar
• Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12: 40–79.
   PubMed Web of Science ®Google Scholar
• Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J Chemother 2000; 12: 463–470.
   PubMed Web of Science ®Google Scholar
• Ribeiro MA, Paula CR, John R, Perfect JR, Cox GM. Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil. Med Mycol 2005; 43: 647–650.
   PubMed Web of Science ®Google Scholar
• Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564–582.
   PubMed Web of Science ®Google Scholar
• Martin KW, Ernst E. Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses 2004; 47: 87–92.
   PubMed Web of Science ®Google Scholar
• Dharmaratne HRW, Piyasena KGNP, Tennakoon SB. A Geranylated biphenyl derivative from Garcinia mangostana. Nat Prod Res 2005; 19: 239–243.
   PubMed Web of Science ®Google Scholar
• Jung HJ, Sung WS, Yeo SH, . Antifungal effect of amentoflavone derived from Selaginella tamariscina. Arch Pharm Res 2006; 29: 746–751.
   PubMed Web of Science ®Google Scholar
• Klausmeyer P, Chmurny GN, McCloud TG, Tucker KD, Shoemaker RH. A novel antimicrobial indolizinium alkaloid from Aniba panurensis. J Nat Prod 2004; 67: 1732–1735.
   PubMed Web of Science ®Google Scholar
• Sautour M, Miyamoto T, Lacaille-Dubois MA. Steroidal saponins from Smilax medica and their antifungal activity. J Nat Prod 2005; 68: 1489–1493.
   PubMed Web of Science ®Google Scholar
• Sohn HY, Son KH, Kwon CS, Kwon GS, Kang SS. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 2004; 11: 666–672.
   PubMed Web of Science ®Google Scholar
• Mandalari G, Bennett RN, Bisignano G, . Antimicrobial activity of flavonoids extracted from bergamot (Citrus bergamia Risso) peel, a byproduct of the essential oil industry. J Appl Microbiol 2007; 103: 2056–2064.
   PubMed Web of Science ®Google Scholar
• Heinonen M. Antioxidant activity and antimicrobial effect of berry phenolics – a Finnish perspective. Mol Nutr Food Res 2007; 51: 684–691.
   PubMed Web of Science ®Google Scholar
• Waterman E, Lockwood B. Active components and clinical applications of olive oil. Altern Med Rev 2007; 12: 331–342.
   PubMed Web of Science ®Google Scholar
• de Leon L, Moujir L. Activity and mechanism of the action of zeylasterone against Bacillus subtilis. J Appl Microbiol 2008; 104: 1266–1274.
   PubMed Web of Science ®Google Scholar
• Roupe KA, Remsberg CM, Yanez JA, Davies NM. Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 2006; 1: 81–101.
   PubMedGoogle Scholar
• Roupe KA, Helms GL, Halls SC, Yanez JA, Davies NM. Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies. J Pharm Pharm Sci 2005; 8: 374–386.
   PubMed Web of Science ®Google Scholar
• Zhang R, Kang KA, Piao MJ, . Rhapontigenin from Rheum undulatum protects against oxidative-stress-induced cell damage through antioxidant activity. J Toxicol Environ Health A 2007; 70: 1155–1166.
   PubMed Web of Science ®Google Scholar
• Park EK, Choo MK, Yoon HK, Kim DH. Antithrombotic and antiallergic activities of rhaponticin from Rhei Rhizoma are activated by human intestinal bacteria. Arch Pharm Res 2002; 25: 528–533.
   PubMed Web of Science ®Google Scholar
• Kim JK, Kim N, Lim YH. Evaluation of the antibacterial activity of rhapontigenin produced from rhapontin by biotransformation against Propionibacterium acnes. J Microbiol Biotechnol 2010; 20: 82–87.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard – 3rd edn. CLSI document M27-A3. Wayne, PA: CLSI, 2008.
   Google Scholar
• Kobayashi D, Kondo K, Uehara N, . Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 2002; 46: 3113–3117.
   PubMed Web of Science ®Google Scholar
• Elorza MV, Rico H, Gozalbo D, Sentandreu R. Cell wall composition and protoplast regeneration in Candida albicans. Antonie Van Leeuwenhoek 1983; 49: 457–469.
   PubMed Web of Science ®Google Scholar
• Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 1999; 37: 3332–3337.
   PubMed Web of Science ®Google Scholar
• Marotti I, Bonetti A, Biavati B, Catizone P, Dinelli G. Biotransformation of common bean (Phaseolus vulgaris L.) flavonoid glycosides by Bifidobacterium species from human intestinal origin. J Agric Food Chem 2007; 55: 3913–3919.
   PubMed Web of Science ®Google Scholar
• Kim Y, Farrah S, Baney RH. Structure-antimicrobial activity relationship for silanols, a new class of disinfectants, compared with alcohols and phenols. Int J Antimicrob Agents 2007; 29: 217–222.
   PubMed Web of Science ®Google Scholar
• Park E, Moon W, Song M, . Antimicrobial activity of phenol and benzoic acid derivatives. Int Biodeterior Biodegrad 2001; 47: 209–214.
   Web of Science ®Google Scholar
• Machlin L, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987; 1: 441–445.
   PubMed Web of Science ®Google Scholar
• Schröter C, Hipler U, Wilmer A, Künkel W, Wollina U. Generation of reactive oxygen species by Candida albicans in relation to morphogenesis. Arch Dermatol Res 2000; 292: 260–264.
   PubMed Web of Science ®Google Scholar
• Phillips AJ, Sudbery I, Ramsdale M. Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Proc Natl Acad Sci USA 2003; 100: 14327–14332.
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39–51.
   PubMed Web of Science ®Google Scholar
• Lincz LF. Deciphering the apoptotic pathway: all roads lead to death. Immunol Cell Biol 1998; 76: 1–19.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010; 48: 749–762.
   PubMed Web of Science ®Google Scholar
• Pasko MT, Piscitelli SC, Van Slooten AD. Fluconazole: a new triazole antifungal agent. DICP 1990; 24: 860–867.
   PubMedGoogle Scholar